BioNxt Solutions Completes Key Funding Milestone
Company Announcements

BioNxt Solutions Completes Key Funding Milestone

BioNxt Solutions (TSE:BNXT) has released an update.

BioNxt Solutions Inc. has successfully completed the second tranche of its non-brokered private placement, issuing 1,000,000 common shares at $0.27 each for a total of $270,000. This brings them closer to their maximum goal of $1,620,000 from the sale of 6,000,000 shares. The funds raised are earmarked for research and development, commercialization programs, and general working capital.

For further insights into TSE:BNXT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBioNxt Advances in Neurodegenerative Drug Delivery
TipRanks Canadian Auto-Generated NewsdeskBioNxt Solutions Explores Collaboration With Gen-Plus
TipRanks Canadian Auto-Generated NewsdeskBioNxt Advances MS Drug with German Pharma Partnership
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App